69. Zero-Copay Generic Drugs & Six-Figure Savings w/ Trace Voshell

69. Zero-Copay Generic Drugs & Six-Figure Savings w/ Trace Voshell

From The Business of Benefits Podcast by Hi Hello Labs Network

January 15, 2026 · 29 min

About this episode

This episode discusses the overlooked cost of generic drug inflation in employer healthcare and how employers can achieve significant savings.

In this episode of The Business of Benefits, host Donovan Ryckis sits down with Trace Voshell, Chief Revenue Officer at GoGoMeds, to expose one of the most overlooked cost drains in employer healthcare: generic drug inflation. While most employers focus on high-cost specialty medications, Trace reveals that generic drugs, covering 80-90% of employees on medication, are systematically overpriced by 30-60% through PBM spread pricing and hidden conflicts of interest. Trace pulls back the curtain on how PBMs profit twice (on adjudication and through ownership of mail order pharmacies), why brokers often block cost-saving solutions (hint: per-script kickbacks), and how employers can bypass these roadblocks even when they feel "handcuffed" to large carrier PBMs. With real case studies showing $45,000 to $140,000+ in annual savings, this episode proves that transparent cost-plus pharmacy pricing can deliver six-figure savings while offering employees zero-copay medications. What You'll Learn: - Why generic drugs represent the biggest overlooked savings opportunity in pharmacy benefits - How PBM "spread pricing" allows them to pocket the difference between what they charge you and what…

People in this episode

Host: Donovan Ryckis

Guest: Trace Voshell

Topics covered

Keywords

Mentioned in this episode

Organizations: GoGoMeds

More episodes of The Business of Benefits Podcast

Explore listener stats, chart rankings, contacts and more on the The Business of Benefits Podcast podcast page.